WO/2015/057160 A NOVEL METHOD OF IN-GAME VOICE CHAT COMMUNICATION SYSTEM||WO||23.04.2015|
||PCT/SG2013/000445||MOZAT PTE LTD||YIN, Xinyi|
This invention relates to a method and system for providing an in-game voice chat communication on mobile communication devices to enable players to communicate with one another verbally while playing games on mobile communication devices. This invention seeks to overcome the limitations of mobile games whereby the players are not able to verbally communicate with one another effectively while playing games without interrupting the game playing experience, and thereby increasing the gaming satisfaction of mobile game players.
WO/2015/057158 DISCOUNT, REVIEW, & REWARD SYSTEM||WO||23.04.2015|
||PCT/SG2013/000441||NG, Chau Siong||NG, Chau Siong|
There is provided a system (100) comprising: a vendor review module (110) configured to receive customer feedback on a plurality of vendors (106); and a customer reward module (110) configured to store a plurality of reward accounts for each respective customer. The customer reward module (110) credits each customer's reward account with a predetermined reward if that customer shares, with at least one other customer, a link to an item or store of items purchaseable within the system (100); and if the least one other customer completes a sale or purchase based on the link.
WO/2015/057159 MICROFLUIDICS SORTER FOR CELL DETECTION AND ISOLATION||WO||23.04.2015|
||PCT/SG2013/000442||CLEARBRIDGE BIOMEDICS PTE LTD||BHAGAT, Ali Asgar S.|
A microfluidic device is disclosed. The device comprises at least one inlet for receiving circulating tumor cells and other cells in a sample; at least one curvilinear and/or spiral channel through which the sample is caused to undergo partial or complete Dean cycles to isolate the circulating tumor cells from the other cells; and at least one outlet configured to communicate with the channel for providing the isolated circulating tumor cells. The channel is configured to provide a predetermined Force ratio based on a desired threshold cell size of the circulating tumor cells. A corresponding method of manufacturing of the device, and a related diagnostic system are also disclosed.
WO/2015/057164 CIRCUIT ARRANGEMENT AND METHOD OF OPERATING THE SAME||WO||23.04.2015|
||PCT/SG2014/000482||NANYANG TECHNOLOGICAL UNIVERSITY||CHAN, Pak Kwong|
A circuit arrangement may include a charge sensing stage and an input stage coupled to the charge sensing stage. The input stage may include an input switching mechanism configured to provide a first charge signal to the charge sensing stage when a first control signal is applied and to provide a second charge signal to the charge sensing stage when a second control signal is applied. The circuit arrangement may further include an output stage coupled to the charge sensing stage. The output stage may include a first output node, a second output node and an output switching mechanism configured to couple the charge sensing stage to the first output node when a third control signal is applied to the output switching mechanism and to couple the charge sensing stage to the second output node when a fourth control signal is applied to the output switching mechanism.
WO/2015/057170 NANOPARTICLE-CONTAINING HYDROGELS||WO||23.04.2015|
||PCT/SG2014/000493||AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH||HAUSER, Charlotte A. E.|
There is provided a nanoparticle-containing hydrogel comprising metal nanoparticles and at least one peptide. The nanoparticle-containing hydrogel may possess antibacterial activity. There is also provided a method for preparing the nanoparticle-containing hydrogel, and compositions and uses thereof.
WO/2015/057171 SEMICONDUCTOR DEVICE FABRICATION||WO||23.04.2015|
||PCT/SG2014/000495||AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH||BERA, Lakshmi Kanta|
There is provided a method for fabricating a semiconductor device having the following structure, and comprising the steps of growing a nucleation layer on a substrate; depositing a binary layer over the nucleation layer; and annealing the binary layer to form a first contact area and a second contact area on the substrate, wherein the annealed binary layer comprises a group 14 element selected from Si, Ge or their combination thereof, and the annealed binary layer in the first and second contact areas are capable of providing a lower contact resistance for a current to flow in the device. This method serves to provide an intermediate layer which enables the fabrication process to become CMOS compatible.
WO/2015/057166 AN INTERFACE FOR PACKAGING A MICROFLUIDIC DEVICE||WO||23.04.2015|
||PCT/SG2014/000487||CLEARBRIDGE BIOMEDICS PTE LTD||BHAGAT, Ali Asgar S.|
An interface comprising: a plurality of external ports configured to fluidically communicate with a plurality of ports of a fluidic delivery platform; and a plurality of engaging conduits configured to fluidically communicate with a plurality of ports of a microfluidic biochip, wherein a tolerance of both the plurality of external ports and/or the plurality of engaging conduits is significantly tighter than a tolerance of the plurality of ports of the microfluidic biochip.
WO/2015/057167 DRIVE DEVICE AND VEHICLE||WO||23.04.2015|
||PCT/SG2014/000488||NANYANG TECHNOLOGICAL UNIVERSITY||SCHIER, Michael|
For providing a drive device (100) for driving a vehicle, especially an electric motor device for driving a motor vehicle, with said drive device being compactly formed and by means of which a fluid can be compressed and/or driven in an energy efficient way, a drive device is suggested comprising: a drive motor (104) for driving a driveshaft (108) of the drive device, and a compressor device (120) for compressing and/or driving a fluid, wherein the drive motor and the compressor device are arranged in a common housing (114) of the drive device and can be mechanically coupled to each other.
WO/2015/057163 METHOD OF CLEANING A HEAT EXCHANGER||WO||23.04.2015|
||PCT/SG2014/000480||HVS ENGINEERING PTE LTD||CHOW, Kok Heng, Alex|
The invention relates to a method for cleaning a heat exchanger. The heat exchanger comprises a plurality of tubes extending between a first header and a second header, and further comprises an insertion unit for introducing a plurality of projectiles thereinto. A first step of the method comprises pumping a fluid into the first header. A second step comprises inserting the plurality of projectiles into the fluid, such that the plurality of projectiles are distributed within the fluid. A third step comprises flowing the fluid and the projectiles through the tubes, such that the projectiles abrades at least one tube. A fourth step comprises discharging the fluid and the projectiles out of the second header. Among the plurality of projectiles, at least one projectile has a different specific gravity, relative to the fluid, from at least one of the remaining projectiles.
WO/2015/057169 SENSE-ANTISENSE GENE PAIRS FOR PATIENT STRATIFICATION, PROGNOSIS, AND THERAPEUTIC BIOMARKERS IDENTIFICATION||WO||23.04.2015|
||PCT/SG2014/000492||AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH||GRINCHUK, Oleg|
The present invention relates to a method of identification of clinically and genetically distinct sub-groups of patients subject to a medical condition, particularly breast, lung, and colon cancer patients using a composition of respective gene expression values for certain gene pairs. Sense-antisense gene pairs (SAGPs) which are relevant for a medical condition and the disease prognosis are used by the method to generate statistical models based on the expression values of the SAGPs. SAGPs for which the statistical models are found to have high value in prognosis of the variation of medical condition and the diseases are selected and integrated in the prognostic signature including specified parameters (e.g. cut-off values) of the prognostic model. It further relates to using respective gene expression values for these genes to predict patient' risk groups (in context of patient's survival or/and disease progression) and to using the predicted groups for identification of patient risk, and specific and robust prognostic biomarkers with mechanistic interpretations of biological changes (associated with the gene signatures) appropriating for an implementation of therapeutic targeting.